key: cord-0723470-rez3zo0p
authors: Hali, Fouzia; Jabri, Houda; Chiheb, Soumiya; Hafiani, Yassine; Nsiri, Afak
title: A concomitant diagnosis of COVID‐19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report
date: 2021-04-17
journal: Int J Dermatol
DOI: 10.1111/ijd.15592
sha: 2c52b0ed3931a81e7b9f77df7529fcc86efcb459
doc_id: 723470
cord_uid: rez3zo0p

nan

Systemic lupus erythematosus (SLE) is an autoimmune, chronic, and multifactorial disease with multi-systemic involvement, characterized by the breaking of tolerance toward nuclear self-antigens inducing the production of pathogenic autoantibodies.

Viral antigens are already known to be potential triggers of SLE. Few reports theorized that SARS-CoV-2 could also be implicated in the SLE pathogenesis. 1 A 25-year-old female patient, with no particular medical history, presented to our dermatology department with a 15-day history of a rash with diffuse myalgias, asthenia, and fever.

Upon physical examination, the patient was conscious, afebrile with stable underlying respiratory status. Skin examination revealed a diffuse maculopapular exanthema with palmarplantar involvement, periorbital edema (Fig. 1a) , infiltrated purpuric lesions of the lower limbs, with multiple labial and palatal erosions. (Fig. 1b) . Anamnesis did not objectify photosensitivity, hair loss, or joint paint, nor any drug intake in the previous year. HIV, syphilis, and rickettsiosis were suspected and serologically discarded in our patient.

Chest computed tomography (CT) scan was performed and showed bilateral pulmonary infiltrates of probable viral origin, the polymerase chain reaction PCR test on a nasopharyn- On the same note, higher serum levels of these same proinflammatory cytokines were found in patients with severe COVID-19, which could explain the onset of SLE in COVID-19 patients. 1 Another interesting aspect of our case is the development of MAS syndrome following the SLE diagnosis. The MAS is probably due to a cytokine "storm" and immune dysregulation caused by the SARS-CoV-2 leading to severe tissue damage. 5 This being said, clinicians should remain careful while diagnosing SLE in the setting of COVID-19 as clinical symptoms of COVID-19 can easily mimic SLE symptoms, and 

The correlation between SARS-CoV-2 infection and rheumatic disease

The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection

Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient

Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology

Macrophage activation syndrome and COVID-19